Bayer to invest $3.2 million in Guatemala

The Bayer Central America and the Caribbean Group will invest in remodeling their Consumer Care Division factory.

Wednesday, November 19, 2008


©image:

Located on Roosevelt Road, it is where they produce over-the-counter (OTC) medications such as Alka-Seltzer, Tabcín, Cafiaspirina and Alive, to name a few.

The production plant is thought to be one of the most important for the German group, Bayer, since it is the third largest on the world market for OTC's and produces 3 million pills daily, of which 12% is exported to Mexico and the rest to Central America and the Caribbean.



Market Intelligence

Everything about medication imports and exports in Guatemala.

Top companies - Quantities, amounts and prices.

more info

More on this topic

Bayer Enlarges Guatemalan Facility

June 2010

Before the end of the year, the multinational corporation will inaugurate an extension of to its medicine production facility in Mixco.

In this facility, the company manufactures over-the-counter medicines such as Alka-Seltzer, Tabín, Cafiaspirina and Alive.

Bayer president Mathías Kremer is in Guatemala, presenting the company’s sustainability plan.

Increased Investment in Pharmaceutical Plant

July 2011

Bayer has invested $5.1 million in its plant in Guatemala in order to increase production by 10%.

As explained by Miguel Angel Parada, Consumer Care director for Bayer Central America and the Caribbean, the plant has a total capacity of 1,500 million tablets, of which 72% are currently sold in the 7 Central American countries.

El Salvador: $40 million Medicine Plant

October 2015

VIJOSA laboratories has started construction of a plant for producing medicines in an area of ​​9 blocks in Santa Tecla, department of La Libertad.

The plant will be located in an area of ​​9 blocks on the road to Santa Tecla, and the work will be developed by the German company Bosch, which will build the project under the turnkey contract scheme.

Bayer invests $65 million in El Salvador

September 2008

The company's plans contemplate investing another $8 million in a plant located in Ilopango and exporting to South America.

Since the Bonima Corporation changed hands to Bayer, the plant located in Ilopango has received $65 million in investment from the European Company, according to management.

 close (x)

Receive more news about Infrastructure and Construction

Suscribe FOR FREE to CentralAmericaDATA EXPRESS.
The most important news of Central America, every day.

Type in your e-mail address:

* Al suscribirse, estará aceptando los terminos y condiciones


Caribbean Central American Action

Caribbean-Central American Action (CCAA) is a private, independent organization that promotes private sector-led economic development in the Caribbean Basin and throughout the Hemisphere.
Operates in Panama, Nicaragua, Honduras, Guatemala, El Salvador, Costa Rica and Caribbean Community
Phone: (202) 331-9467

Company Profile

Stock Indexes

(Dec 2)
Dow Jones
-0.11%
S&P 500
0.04%
Nasdaq
0.09%

Commodities

(Dec 2)
Brent Crude Oil
55.140
Coffee "C"
145.85
Gold
1,178
Silver
16.735